Get access to Hummingbird’s miRNA Biomarker Platform

Partnering

Enhanced clinical drug development

  • Patient stratification (responders)
  • Disease & treatment monitoring marker
  • Immunological status
  • Toxicological & adverse event marker

Diagnostic development

  • Early diagnosis
  • Prognosis
  • Companion Diagnostics

Access to ip portfolio

  • Out-licensing
  • Co-development

Hummingbird’s Clinical Partners - Valued Contributors to our Success

Clinical partners

Clinical partners

Interested in collaboration?
Please contact us!

Get access to Hummingbird’s miRNA Biomarker Platform

IP

Dominant IP in whole blood

  • 34 patent families
  • Encompassing all major disease groups
  • 140 patents granted/validated

Access to ip portfolio

  • Out-licensing
  • Co-development